CSANZ Admin Member News

WHF 2023 guidelines for the echocardiographic diagnosis of Rheumatic Heart Disease

The World Heart Federation (WHF) 2023 guidelines for the echocardiographic diagnosis of rheumatic heart disease were presented at the World Congress on Rheumatic Heart Disease in Abu Dhabi in November and simultaneously published in Nature Reviews Cardiology.

The 2023 revision of the WHF guidelines defines the minimum criteria for diagnosing RHD based on the best-available evidence. They introduce two new sets of diagnostic criteria, screening, and confirmatory criteria, and outlines best application of each. In addition, a stage-based classification of RHD, based on the risk of disease progression has been presented. The guidelines also provide recommendations for the management of early stages of RHD, offering comprehensive guidance to healthcare professionals in RHD-endemic regions worldwide.

Download publication here (pdf)

CSANZ Admin Latest news

CSANZ 2024 | ANZET24 | See you in Perth from 1-4 August 2024

Start planning your trip to Perth, WA for the 2024 CSANZ ASM and ANZET24 Meeting.

An exciting Program is coming together, the Named Lecturers and the International Faculty are confirming their spots at the podium and Abstract Submission is open for an exciting 72nd Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand.

Click on the video to see what Perth has in store for you!

 

 

Read more about the  INTERNATIONAL AND NATIONAL FACULTY as they confirm. 

 

 

Watch this space for the launch of the program when it is confirmed.

SUBMIT YOUR ABSTRACTS NOW 
csanzasm.com
anzet.com.au
CSANZ Admin Notice Board

Heart Failure Research Review Issue 81, with commentary by Prof Andrew Coats

In this edition:

–  Semaglutide in HFPEF according to obesity/weight loss
–  Catheter ablation for end-stage HF with AF
–  Adaptive vs. conventional CRT for HF
–  NYHA class and KCCQ in acute HF
–  Remote multiparameter monitoring for guiding HF management
–  Upgrade of right ventricular pacing to CRT in HF
–  Update of ESC HF guidelines
–  Mortality, outcomes, costs and medication use after first HF hospitalisation
–  MRA initiation during admission improves outcomes in acute HF

Download Heart Failure Research Review Issue 81 as a pdf here 

CSANZ Admin Latest news

2024 CSANZ ASM /ANZET ABSTRACTS ARE OPEN

 

CSANZ 2024 and ANZET24 Abstracts are now OPEN for submission.  

Please read all the guidelines and submission requirements carefully.

Learn more about the prestigious Ralph Reader Prize eligibility criteria and application here.

CSANZ Cardiology stream prizes that are on offer this year are:

Allied Health Science and Technology Prize  |   Cardiac Imaging Prize  |   Cardiovascular Genetic Diseases Prize  |   Cardiovascular Nursing Prize  |   Clinical Trials Prize  |   Heart Rhythm Prize  |   Heart Failure Prize  |   Indigenous Health Prize  |   Paediatric and Congenital Cardiology Prize  |   Prevention Prize.

Abstracts can be submitted for one or more of the Prizes however, the work may only be presented in one prize final session. All abstract submissions close on 11 March 2024 at 20:00 AEDT.

ANZET Prizes on offer include:

* The ANZET Early Career Research Award closes on 11 March 2024 at 20:00 AEDT.

^   Applications for the Geoff Mews Memorial Fellow’s Prize and the Best Interventional Imaging Competition close on 12 June 2024 at 20:00 AEDT.

CSANZ Admin News Archive

Empagliflozin is now on the PBS – Read more here including accessing the Online PBS Authorities system

Empagliflozin (Jardiance®) (10 mg tablet) is now listed on the PBS for the treatment of chronic heart failure.

Chronic heart failure

Empagliflozin (Jardiance®) (10 mg tablet) is now listed on the PBS for the treatment of chronic heart failure. Prescriptions for treatment are Authority Required (STREAMLINED).

Download the Frequently Asked Questions (FAQs) relating to access and including the use of the Online PBS Authorities system  

For more information about the Online PBS Authorities system visit www.servicesaustralia.gov.au/hppbsauthorities

CSANZ Admin Device Alerts

Medtronic – LINQ II ™ implantable cardiac monitor (Nov 2023)

A subset of devices with a manufacturing defect are susceptible to increased noise due to moisture affecting the electrode performance.

Device:
Medtronic LINQ II Implantable Cardiac Monitor (LNQ22)

TGA Reference:
RC-2023-RN-00930-1

Australian Register of Therapeutic Goods (ARTG):
391830 and 355313

ANZCDACC Management Recommendations for Medtronic LINQ II Alert
November 2023

Download PDF

Read More
CSANZ Admin Notice Board

Cardiac adverse reactions associated with cancer immunotherapy – Research Review Education Series

A new Research Review Educational series on cardiac adverse reactions associated with cancer immunotherapy.  This series summarises the impact, diagnosis, and management of cardiac immune-related adverse reactions in these patients, using current clinical consensus. The review also presents and discusses two cases of ICI-associated myocarditis with very different outcomes.

Independent commentary is provided by Dr James Pemberton, a cardiologist currently working at Dunedin and Invercargill Hospitals.

 Download Educational_Series_Cardiac_Adverse_Reactions_and_Immunotherapy (pdf)

CSANZ Admin Notice Board

Cardiology Research Review Issue 158, with commentary by A/Prof John Amerena

In this issue:

  • ANGPTL3 might be a suitable target for triglyceride and cholesterol lowering
  • Complete vs culprit-only PCI in older patients with MI
  • Catheter ablation reduces psychological distress in patients with AF
  • Outcomes of thrombus aspiration during PCI for STEMI
  • Benefits of lipid-lowering therapy for primary prevention in the elderly
  • Outcomes after PCI in patients with ischaemic LV dysfunction
  • Prognostic significance of ventricular ectopic beats during exercise
  • Ten-year cardiovascular risk in patients with newly diagnosed type 2 diabetes
  • Impact of smoking status on cardiovascular outcomes after PCI

Download Cardiology_Research_Review_Issue_158 (pdf)

CSANZ Admin Notice Board

Heart Failure Research Review: Issue 80, with commentary by Dr Mark Nolan

In this edition:

–  Ferric carboxymaltose in HF with iron deficiency
–  Semaglutide in HFPEF and obesity
–  Clinical characteristics and HF outcomes: LVEF thresholds and inflection points
–  Obesity in HFPEF with or without diabetes
–  VAI and HF risk, late-life cardiac structure and function
–  Blinded withdrawal of long-term empagliflozin or placebo in HF
–  Cardiac and metabolic effects of dapagliflozin in HFPEF
–  Age, sex and outcomes in HFREF
–  5-year mortality in patients managed with magnetically levitated LVAD
–  MRA underutilisation in HFREF

Download  Heart_Failure_Research_Review_Issue_80 (pdf)

CSANZ Admin News Archive

R T Hall Prize

We are delighted to announce the 2023 R T Hall Prize is awarded to Prof Gemma Figtree AM. The RT Hall Prize is the most prestigious research award of CSANZ and recognises the achievements of senior and established investigators.

Over the last 10 years Prof Figtree has led an expanding international team addressing the mechanisms and unmet needs regarding clinical pathways for patients who develop coronary artery disease and myocardial infarction despite no standard modifiable risk factors (SMuRFs).

She is the National Scientific Lead of the large global clinical trial AEGIS II and was appointed to the adjudication panel, co-leading the heart failure analyses and publications for the highly cited CANVAS program demonstrating of benefits of SGLT2 inhibition in diabetics.

Using validated pre-clinical models, she has made seminal contributions that have provided unique insights into the mechanisms of cardiovascular disease susceptibility.

An impressive line up!

Captured at this year’s CSANZ ASM was an impressive line up of previous R T Hall Prize winners. Pictured together here, at the 2023 CSANZ ASM President’s Welcome on Thursday evening – an “RT Hall Prize Hall of Fame”. 

View the full list R T Hall Prize winners below from 1965 to date. 

RT Hall Prize Winners

(from left to right): Prof Paul Nestel (awarded in 1965, the first RT Hall Prize recipient), guest with Prof Gerald Watts (2022), Prof Phil Aylward (1984) and Prof Stephen Nicholls (2018). 

 

Posts navigation

1 … 5 6 7 8 9 10 11 12 13 14 15 … 31